Collectively, these results suggested that B7-H4 alters the expression of survivin, which can subsequently inhibit the caspase-3–caspase-7 and Bax pathways; eventually, apoptosis in HCC cells is blocked. This evidence concerns the gene VTCN1 and hepatocellular carcinoma.